Related Experiment Video
Updated: Jul 14, 2026
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Proteomic analysis to dissect mitoxantrone resistance-associated proteins in a squamous lung carcinoma
1National Institute of Cellular Biology, Dublin City University, Ireland.
Background:
Mitoxantrone resistance has been related to the expression of a drug efflux pump breast cancer resistance pump (BCRP) but little is known of the intracellular protein changes. In this work, differential protein expression in a squamous lung carcinoma cell line, DLKP, and its mitoxantrone-resistant variant (DLKP-Mitox) was investigated to elucidate other changes associated with mitoxantrone resistance.
Materials And Methods:
Differential protein expression between DLKP and DLKP-Mitox was investigated using 2D-DIGE technology. Proteins of interest were identified by MALDI-ToF mass spectrometry. Western blotting was used to confirm and validate some of these changes.
Results:
Biological variation analysis in Decyder software revealed a total of 343 proteins to be differentially regulated with p < 0.05. Identification of 61 proteins of interest by mass spectrometry revealed changes in proteins involved in many cellular processes including apoptosis and differentiation.
Conclusion:
Alterations in these cellular processes and proteins present alternative sites to circumvent resistance to mitoxantrone.
Insights
Researchers explored intracellular protein changes in lung cancer cells resistant to mitoxantrone. They identified altered proteins involved in apoptosis and differentiation, offering new targets to overcome drug resistance.
Area of Science:
- Proteomics
- Cancer Biology
- Molecular Oncology
Background:
- Mitoxantrone resistance in cancer is linked to drug efflux pumps like breast cancer resistance pump (BCRP).
- Intracellular protein alterations contributing to mitoxantrone resistance remain largely uncharacterized.
- This study investigates differential protein expression in a lung carcinoma cell line and its mitoxantrone-resistant variant.
Purpose of the Study:
- To identify novel intracellular protein changes associated with mitoxantrone resistance.
- To elucidate molecular mechanisms beyond BCRP that contribute to drug resistance.
- To discover potential therapeutic targets for overcoming mitoxantrone resistance.
Main Methods:
- Utilized 2D-Differential Gel Electrophoresis (2D-DIGE) for differential protein expression analysis.
- Employed MALDI-ToF mass spectrometry for identification of differentially expressed proteins.
- Confirmed protein expression changes using Western blotting.
Main Results:
- Identified 343 differentially regulated proteins (p < 0.05) between sensitive and resistant cell lines.
- Mass spectrometry identified 61 proteins of interest.
- Detected significant alterations in proteins associated with apoptosis and cellular differentiation.
Conclusions:
- Discovered significant intracellular protein expression changes beyond BCRP in mitoxantrone-resistant lung cancer cells.
- Identified alterations in apoptosis and differentiation pathways as key contributors to mitoxantrone resistance.
- These findings suggest alternative molecular targets for circumventing mitoxantrone resistance.